Geographic · Property, plant and equipment

International — Property, plant and equipment

Bristol-Myers Squibb International — Property, plant and equipment increased by 44.6% to $2.32B in Q4 2024 compared to the prior quarter.

Analysis

StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ4 2021
Last reportedQ4 2024
Rolls up toPP&E (Net)

How to read this metric

An increase suggests expansion of international manufacturing or research infrastructure, while a decrease may indicate asset divestiture, impairment, or a shift toward third-party contract manufacturing.

Detailed definition

This metric represents the net book value of tangible long-term assets, such as manufacturing facilities, laboratories,...

Peer comparison

Peer pharmaceutical companies typically report this as part of their regional segment disclosures, with levels varying based on whether the firm utilizes internal manufacturing or outsourced production models.

Metric ID: bmy_segment_international_property_plant_and_equipment

Historical Data

4 periods
 Q4 '21Q4 '22Q4 '23Q4 '24
Value$1.34B$1.42B$1.61B$2.32B
QoQ Change+6.2%+12.9%+44.6%
YoY Change+6.2%+12.9%+44.6%
Range$1.34B$2.32B
Avg YoY Growth+21.2%
Median YoY Growth+12.9%
Current Streak3+ quarters growth

Frequently Asked Questions

What is Bristol-Myers Squibb's international — property, plant and equipment?
Bristol-Myers Squibb (BMY) reported international — property, plant and equipment of $2.32B in Q4 2024.
What does international — property, plant and equipment mean?
The total value of physical assets like factories and equipment owned by the company in international markets.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.